Research Peptides
Explore 85 pharmaceutical-grade peptides organized by research application. Use filters to find exactly what you need.
85 products
Filter
Goals
Categories
Sort
85 results
Tirzepatide
Dual GIP and GLP-1 receptor agonist. Among the most potent metabolic peptides studied to date, with clinical trials reporting up to 21% body weight reduction.
Semaglutide
Long-acting GLP-1 receptor agonist. STEP-1 trial reported 14.9% average body weight reduction at 2.4mg weekly dose over 68 weeks.
Retatrutide
Triple GLP-1, GIP, and glucagon receptor agonist. Phase 2 data reported up to 24.2% body weight reduction at 12mg weekly dose over 48 weeks.
BPC-157
Body Protection Compound 157 accelerates healing of tendons, ligaments, muscle, and gut tissue through angiogenesis and growth factor upregulation.
TB-500 (Thymosin Beta-4)
Thymosin Beta-4 fragment that promotes systemic tissue repair, reduces inflammation, and accelerates recovery from muscle, tendon, and cardiac injuries via
GHK-Cu
Naturally occurring copper-binding tripeptide (Gly-His-Lys-Cu2+) present in human plasma. Plasma levels decline 60% between ages 20-60. Studied for collagen
CJC-1295 without DAC
Modified GHRH fragment (Mod GRF 1-29) that produces acute, physiological GH pulses when combined with a GHRP. The standard pairing with ipamorelin for clean GH
Ipamorelin
Highly selective growth hormone secretagogue with minimal cortisol or prolactin stimulation, offering clean GH pulses for muscle growth, recovery, and body
CJC-1295 + Ipamorelin Combo
The gold-standard GH secretagogue combination - CJC-1295 (GHRH receptor) and Ipamorelin (ghrelin receptor) producing synergistic, pulsatile GH release 3-5x
NAD+
Nicotinamide adenine dinucleotide coenzyme found in every living cell. Substrate for sirtuins and PARP enzymes; declines with age. Studied for metabolic
Semax
ACTH(4-7) analogue with potent nootropic and neuroprotective properties. Upregulates BDNF and NGF, approved in Russia for stroke recovery and cognitive
Selank
Synthetic heptapeptide anxiolytic developed by the Russian Academy of Sciences. Reduces anxiety without sedation, improves memory consolidation, and
PT-141 (Bremelanotide)
FDA-approved melanocortin receptor agonist (Vyleesi) for hypoactive sexual desire disorder. Acts centrally on MC3R/MC4R to restore sexual motivation without
IGF-1 LR3
Long-acting IGF-1 analogue with 3x longer half-life than native IGF-1, driving satellite cell activation, nitrogen retention, and protein synthesis for maximal
Melanotan II
Cyclic alpha-MSH analogue activating MC1R through MC4R. Produces tanning, sexual effects, and appetite suppression simultaneously. Widely studied for
Epithalon
Synthetic tetrapeptide (Ala-Glu-Asp-Gly) derived from the pineal gland. Studied for telomerase activation, telomere elongation, and lifespan extension in
HGH (Somatropin) 191aa
Recombinant 191-amino acid human growth hormone identical to pituitary-derived GH. Used as the reference standard in GH axis research for body composition
GHRP-2
Second-generation GHRP with potent GH-releasing activity and mild ghrelin-like effects on appetite, studied for GH deficiency, muscle preservation, and
GHRP-6
First-generation GHRP with potent GH-releasing activity and strong appetite stimulation, widely used in research for GH axis studies and muscle wasting models.
AOD 9604
Modified fragment of human growth hormone (hGH 177-191) with selective lipolytic activity and no reported effect on blood glucose or IGF-1. Studied for adipose
HGH Fragment 176-191
C-terminal fragment of human growth hormone (amino acids 176-191) with potent lipolytic activity. Studied for adipose reduction without the growth-promoting or
TB-500 Fragment
The isolated LKKTETQ core fragment of Thymosin Beta-4, delivering the primary actin-sequestration activity in a smaller, more focused peptide sequence.
BPC-157 + TB-500 Combo
The definitive tissue repair stack - BPC-157 and TB-500 together in a single kit. Complementary mechanisms address both local vascular repair and systemic cell
Liraglutide
Daily GLP-1 receptor agonist with a 13-hour half-life. SCALE trials at 3mg daily dose showed average weight reductions of 8% over 56 weeks.
Sermorelin
Native GHRH(1-29) fragment that has the most clinical history of all GHRH peptides. Studied extensively for age-related GH decline and HPA axis normalisation.
Tesamorelin
FDA-approved GHRH analogue (Egrifta) for HIV-associated visceral fat reduction. The most clinically validated GHRH peptide for abdominal fat mobilisation and
CJC-1295 with DAC
Long-acting GHRH analogue with Drug Affinity Complex technology that binds albumin for a half-life of 6-8 days, sustaining elevated GH and IGF-1 for continuous
Thymosin Alpha-1 (Ta1)
FDA-designated immunomodulator (Zadaxin) approved in 35+ countries for hepatitis B, hepatitis C, and cancer immunotherapy. Activates T-cells and dendritic
Cagrilintide
Long-acting amylin receptor agonist with a 7-day half-life. Studied for weight management both as monotherapy and in combination with semaglutide (CagriSema).
Cagrisema
Pre-formulated combination of cagrilintide (amylin analog) and semaglutide (GLP-1 agonist). Phase 2 data showed 15.6% weight reduction with a favourable
Mazdutide
Once-weekly dual GLP-1 and glucagon receptor agonist developed by Innovent Biologics. Phase 2 data in a Chinese population showed up to 11.3% weight reduction
Survodutide
Dual GLP-1 and glucagon receptor agonist developed by Boehringer Ingelheim. Phase 2 data showed 19% weight reduction at the highest dose over 46 weeks.
Kisspeptin-10
C-terminal decapeptide of kisspeptin that activates GPR54 to trigger GnRH pulse release, driving LH, FSH, and testosterone surges. Central regulator of the
5-Amino-1MQ
Nicotinamide N-methyltransferase (NNMT) inhibitor. Blocks the primary NAD+ consuming pathway outside mitochondria, raising cellular NAD+ levels and activating
AC-262 (ADMAX)
Selective androgen receptor modulator (SARM) with tissue-selective anabolic activity in muscle and bone, investigated for muscle wasting and testosterone
Acetic Acid Solution 0.6% (10ml)
0.6% sterile acetic acid for reconstituting IGF-1 LR3 and growth factors that are unstable in neutral pH bacteriostatic water.
Adipotide (FTTP)
Pro-apoptotic peptide that selectively targets vasculature within white adipose tissue, inducing adipocyte death via disruption of blood supply. Studied in
AHK-Cu
Copper-binding tripeptide (Ala-His-Lys-Cu2+) with structural similarity to GHK-Cu. Primarily studied for hair follicle stimulation, scalp vascularity, and
AICAR
AMPK activator that mimics exercise-induced metabolic signalling, increasing mitochondrial biogenesis, fat oxidation, and endurance capacity without mechanical
ARA-290
Non-haematopoietic EPO analogue that activates the Innate Repair Receptor (IRR) for tissue protection, pain reduction, and anti-inflammatory effects without
B7-33
Single-chain relaxin B-chain analog targeting the RXFP1 receptor. Studied for anti-fibrotic effects in cardiac, renal, and pulmonary fibrosis models without
Bacteriostatic Water (30ml)
USP-grade bacteriostatic water containing 0.9% benzyl alcohol. Required for reconstituting research peptides to allow multi-dose vial use for up to 28 days.
Botulinum Toxin Type A
Clostridium botulinum neurotoxin type A that cleaves SNAP-25 to temporarily block neuromuscular acetylcholine release, reducing expression line formation for
Bronchogen
Peptide bioregulator developed by Vladimir Khavinson targeting lung tissue. Studied for organ-specific gene expression normalisation and age-related functional
Cardiogen
Peptide bioregulator developed by Vladimir Khavinson targeting heart tissue. Studied for organ-specific gene expression normalisation and age-related
Cartalax
Peptide bioregulator developed by Vladimir Khavinson targeting cartilage tissue. Studied for organ-specific gene expression normalisation and age-related
Cerebrolysin
Porcine brain-derived peptide mixture mimicking BDNF, NGF, and GDNF. Approved in 50+ countries for Alzheimer's disease and stroke recovery. The most studied
Cortagen
Peptide bioregulator developed by Vladimir Khavinson targeting nervous system tissue. Studied for organ-specific gene expression normalisation and age-related
Crystagen
Peptide bioregulator developed by Vladimir Khavinson targeting connective tissue tissue. Studied for organ-specific gene expression normalisation and
DSIP
Neuropeptide that promotes slow-wave (delta) sleep, modulates cortisol and GH release, and demonstrates stress-reducing and potentially anti-cancer properties
EPO (Erythropoietin)
Recombinant erythropoietin that stimulates red blood cell production, increasing oxygen-carrying capacity. Extensively researched for anaemia, renal disease
FOXO4-DRI
D-retro-inverso peptide that disrupts FOXO4-p53 interaction in senescent cells, selectively triggering apoptosis of senescent cells without harming
G-LOW Combo (GH Optimised Fat Loss)
GH-axis targeted fat loss stack combining tesamorelin and ipamorelin for visceral fat reduction with AOD 9604 for direct adipose lipolysis. Based on the
Glutathione
Endogenous tripeptide (Glu-Cys-Gly) and principal intracellular antioxidant. Injectable formulations achieve plasma levels not possible orally. Studied for
HCG (Human Chorionic Gonadotropin)
Placental glycoprotein hormone with LH-like activity that directly stimulates testicular Leydig cells to produce testosterone. Used for HPTA restoration and
Hexarelin
The most potent synthetic GHRP, with unique CD36-mediated cardioprotective effects studied independently of GH release. Investigated for post-MI cardiac repair
HMG (Human Menopausal Gonadotropin)
Extracted urinary gonadotropin with FSH and LH activity. Used for fertility treatment and spermatogenesis induction in hypogonadotropic hypogonadism research.
Humanin
Mitochondrially-encoded peptide with neuroprotective and metabolic effects. Circulating levels correlate positively with longevity in centenarian studies
K-LOW Combo (Weight Loss Stack)
Research-focused weight management combo combining a GLP-1/GIP receptor agonist with AOD 9604 and Lipo-C for multi-pathway fat mobilisation and metabolic
KPV
C-terminal tripeptide of alpha-MSH with potent anti-inflammatory activity, studied for gut inflammation, inflammatory bowel disease, and skin wound healing via
L-Carnitine
Conditionally essential amino acid derivative that transports long-chain fatty acids into mitochondria for beta-oxidation. Widely studied for fat metabolism
Lipo-C
Lipotropic injection combining methionine, inositol, and choline (MIC). Promotes hepatic fat metabolism, supports bile production, and is used in weight
LL-37
Human cathelicidin antimicrobial peptide with broad-spectrum antibacterial, antiviral, and antifungal activity. Also promotes wound healing and modulates
Matrixyl 3000 (Palmitoyl Tripeptide-1 & Hexapeptide-12)
The most extensively clinically tested anti-aging peptide complex. Matrikine fragments activate fibroblasts to produce collagen I, III, VI, and fibronectin for
Melanotan I (Afamelanotide)
Selective MC1R agonist (Scenesse) approved in EU/US for erythropoietic protoporphyria. Produces sustained melanin-based photoprotection without the behavioural
Melatonin
Pineal hormone that regulates circadian rhythms, scavenges free radicals, and protects mitochondria. The most extensively studied sleep and anti-aging compound
MGF (Mechano Growth Factor)
Local IGF-1 splice variant released by mechanically stressed muscle, activating satellite cells at the injury site for immediate hypertrophic repair. Distinct
MIC (Lipo-C + B12)
Methionine, Inositol, Choline lipotropic complex enhanced with Vitamin B12 (methylcobalamin). Combines hepatic fat mobilisation with neurological and energy
MOTS-c
16-amino acid mitochondria-derived peptide that activates AMPK and suppresses the folate cycle. Studied for metabolic regulation, insulin sensitivity, and
Oxytocin
Hypothalamic neuropeptide that modulates social behaviour, trust, bonding, and stress responses. Widely studied for autism spectrum conditions, PTSD, and
P21
Short peptide fragment derived from CNTF (Ciliary Neurotrophic Factor) that promotes neurogenesis, upregulates BDNF, and enhances synaptic plasticity without
PE-22-28
Synthetic analogue of spadin that blocks the TREK-1 potassium channel, producing rapid antidepressant effects and stimulating hippocampal neurogenesis in
PEG-MGF
PEGylated Mechano Growth Factor with extended 48-hour half-life. Allows subcutaneous delivery of MGF for sustained satellite cell activation without rapid
Pinealon
Tripeptide bioregulator derived from pineal gland extract that normalises melatonin rhythm, protects neurons from oxidative stress, and supports brain function
PNC-27
Penetratin-linked peptide corresponding to the p53 MDM2-binding domain. Studied for selective induction of apoptosis in cancer cells expressing
Retatrutide + Tirzepatide Combo
Triple-receptor and dual-receptor incretins combined for research into maximal GLP-1/GIP/glucagon axis engagement. For comparative pharmacology and
RTT-60 (Retatrutide 60-Day Cycle Kit)
Complete 60-day research cycle of retatrutide with structured dose escalation. Includes all vials, a bacteriostatic water supply, and a dosing guide for the
SLUPP-332
Selective alpha7 nicotinic acetylcholine receptor agonist that enhances cognitive function, working memory, and attention via hippocampal and prefrontal
SNAP-8
Octapeptide that competes with SNAP-25 in the SNARE complex to reduce acetylcholine vesicle release at neuromuscular junctions, reducing expression line depth
SS-31 (Elamipretide)
Aromatic-cationic tetrapeptide (D-Arg-Dmt-Lys-Phe-NH2) that selectively targets the inner mitochondrial membrane. Studied for cardioprotection, mitochondrial
Tesamorelin + Ipamorelin Combo
The anti-aging GH axis stack: tesamorelin (full-length GHRH, FDA-approved mechanism) combined with ipamorelin (selective GHS-R1a) for synergistic GH and IGF-1
Thymalin
Short thymus-derived peptide bioregulator that restores T-cell function and immune competence in aging models. Used in Russian longevity research alongside
Vesugen
Peptide bioregulator developed by Vladimir Khavinson targeting vascular tissue. Studied for organ-specific gene expression normalisation and age-related
VIP (Vasoactive Intestinal Peptide)
28-amino acid neuropeptide with potent anti-inflammatory, bronchodilatory, and gut motility effects. Studied for inflammatory bowel disease, pulmonary
Vitamin B12 (Methylcobalamin)
Injectable methylcobalamin (active form of Vitamin B12). Bypasses gut absorption limitations. Studied for neurological function, methylation cycle support